Displaying drugs 6751 - 6775 of 8297 in total
Ichorcumab
Ichorcumab is under investigation in clinical trial NCT03251482 (A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery).
Investigational
Matched Description: … Ichorcumab is under investigation in clinical trial NCT03251482 (A Study to Evaluate the Safety and Efficacy of …
Pemrametostat
Pemrametostat is under investigation in clinical trial NCT03614728 (Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)).
Investigational
Matched Description: … investigation in clinical trial NCT03614728 (Study to Investigate the Safety and Clinical Activity of …
Abivertinib
Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. In binding to and inhibiting EGFR and BTK receptors,...
Investigational
Matched Description: … Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth ... [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and ... BTK receptors, abivertinib exerts immunomodulatory effects by preventing the production and release of …
Willardiine
Willardiine is a compound isolated from seeds of Acacia willariana.
Experimental
Matched Description: … Willardiine is a compound isolated from seeds of _Acacia willariana_. …
Thenoyltrifluoroacetone
Thenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration.
Experimental
Matched Description: … Thenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration. …
PH-797804
PH-797804 has been investigated for the treatment of Osteoarthritis.
Investigational
Matched Description: … PH-797804 has been investigated for the treatment of Osteoarthritis. …
Bapineuzumab
Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Bapineuzumab has been investigated for the treatment of Alzheimer's Disease. …
Orteronel
Orteronel has been investigated for the treatment of Prostate Cancer.
Investigational
Matched Description: … Orteronel has been investigated for the treatment of Prostate Cancer. …
Piclozotan
Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational
Matched Description: … Piclozotan has been investigated for the treatment of Parkinson's Disease. …
Fanapanel
Fanapanel has been investigated for the treatment of Visual Acuity.
Investigational
Matched Description: … Fanapanel has been investigated for the treatment of Visual Acuity. …
Cannabinol
Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Experimental
Investigational
Matched Description: … Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa. …
LY-2183240
LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.
Investigational
Matched Description: … LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037] …
BBP-671
BBP-671 is a small molecule activator of pantothenate kinases.
Investigational
Matched Description: … BBP-671 is a small molecule activator of pantothenate kinases. …
Bi104
Bi104 is being investigated for the treatment of Angelman syndrome.
Investigational
Matched Description: … Bi104 is being investigated for the treatment of Angelman syndrome. …
Eldecalcitol
Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation.
Investigational
Matched Description: … in an estrogen-deficient rat model of osteoporosis. ... Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol …
DP-b99
DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment of stroke, head trauma and neurological damage associated with coronary artery bypass graft.
Investigational
Matched Description: … DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N ... N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment of …
Pranlukast
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Investigational
Corticosterone
An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
Experimental
Matched Description: … (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437) …
Pumactant
Pumactant is a synthetic surfactant used for treating respiratory distress syndrome in neonates. It is a unique formulation of the naturally occurring phospholipids Dipalmitoylphosphatidycholine (DPPC) and Phosphatidyl Glycerol (PG).
Investigational
Matched Description: … It is a unique formulation of the naturally occurring phospholipids Dipalmitoylphosphatidycholine (DPPC …
Filanesib
Filanesib is a potent Kinesin Spindle Protein (KSP) inhibitor that caused marked tumor regression in preclinical models of human solid tumors and human leukemias, often leading to durable responses.
Investigational
Matched Description: … potent Kinesin Spindle Protein (KSP) inhibitor that caused marked tumor regression in preclinical models of …
Patritumab
Patritumab has been used in trials studying the treatment of LUNG CANCER, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms, and Non-small Cell Lung Cancer, among others.
Investigational
Matched Description: … Patritumab has been used in trials studying the treatment of LUNG CANCER, Solid Tumors, Neoplasms by …
Apricoxib
Apricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, and Metastatic Pancreatic Cancer, among others.
Investigational
Matched Description: … Apricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer …
Dipropyl-4-hydroxytryptamine
Dipropyl-4-hydroxytryptamine is the 4-hydroxyl analog of dipropyltryptamine (DPT). Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. This agent and its properties haven't been fully elucidated.
Experimental
Matched Description: … Dipropyl-4-hydroxytryptamine is the 4-hydroxyl analog of dipropyltryptamine (DPT). …
AZD-9977
AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers).
Investigational
Matched Description: … is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of …
AGG-523
AGG-523 is under investigation in clinical trial NCT00380900 (Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy subjects and in subjects with osteoarthritis).
Investigational
Matched Description: … trial NCT00380900 (Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of …
Displaying drugs 6751 - 6775 of 8297 in total